×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!

Drive Efficiency by Bridging Clinical and Commercial Functions

April 26, 2016
The evolving pharmaceutical environment is requiring pharmaceutical companies to bridge the gap between clinical and commercial functions. Joshua Schultz, Corporate VP and Head of PAREXEL Access, explains how PAREXEL Access Real-World Evidence Ecosystem helps clients create efficiencies by bridging clinical and commercial functions to help support both Market Access and Clinical Operations. We help clients design studies that address scientific and clinical needs with the most experienced late stage CRO with 600+ late stage studies in last 5 years.
Previous Video
Identify the Right Real-World Evidence (RWE) Data Sources
Identify the Right Real-World Evidence (RWE) Data Sources

In an evolving Market Access landscape, PAREXEL Access can help alleviate some of the uncertainty on best p...

Next Video
Drive Cost-Efficiencies with Real-World Evidence (RWE)
Drive Cost-Efficiencies with Real-World Evidence (RWE)

Pharmaceutical Companies today need post-approval data to demonstrate product value in an environment where...